According to our database analysis, the ACE1 II genotype frequency in a population was significantly negatively correlated with the number of deaths due to SARS-CoV-2 infection, suggesting that the ACE1 II genotype may favorably influence the prevalence and clinical outcome of COVID-19 [1]. This evidence concerns the gene ACE and COVID-19.